AAAAAA
Results:
1-25
|
Results: 25
Authors:
Ekberg-Jansson, A
Larsson, S
Lofdahl, CG
Citation: A. Ekberg-jansson et al., Preventing exacerbations of chronic bronchitis and COPD - Two recent Cochrane reviews report effective regimens, BR MED J, 322(7297), 2001, pp. 1259-1261
Authors:
Montnemery, P
Bengtsson, P
Elliot, A
Lindholm, LH
Nyberg, P
Lofdahl, CG
Citation: P. Montnemery et al., Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group, RESP MED, 95(9), 2001, pp. 744-752
Authors:
Andersson, F
Stahl, E
Barnes, PJ
Lofdahl, CG
O'Byrne, PM
Pauwels, RA
Postma, DS
Tattersfield, AE
Ullman, A
Citation: F. Andersson et al., Adding formoterol to budesonide in moderate asthma - health economic results from the FACET study, RESP MED, 95(6), 2001, pp. 505-512
Authors:
Arvidsson, P
Lofdahl, CG
Skoogh, BE
Lotvall, J
Citation: P. Arvidsson et al., Exudation of plasma and production of thromboxane in human bronchi after local bradykinin challenge, RESP MED, 95(5), 2001, pp. 313-318
Authors:
Ekberg-Jansson, A
Andersson, B
Bake, B
Boijsen, M
Enanden, I
Rosengren, A
Skoogh, BE
Tylen, U
Venge, P
Lofdahl, CG
Citation: A. Ekberg-jansson et al., Neutrophil-associated activation markers in healthy smokers relates to a fall in DLCO and to emphysematous changes on high resolution CT, RESP MED, 95(5), 2001, pp. 363-373
Authors:
Ekberg-Jansson, A
Bake, B
Andersson, B
Skoogh, BE
Lofdahl, CG
Citation: A. Ekberg-jansson et al., Respiratory symptoms relate to physiological changes and inflammatory markers reflecting central but not peripheral airways. A study in 60-year-old 'healthy' smokers and never-smokers, RESP MED, 95(1), 2001, pp. 40-47
Authors:
Montnemery, P
Svensson, C
Adelroth, E
Lofdahl, CG
Andersson, M
Greiff, L
Persson, CGA
Citation: P. Montnemery et al., Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema, EUR RESP J, 17(4), 2001, pp. 596-603
Authors:
Thorsson, L
Edsbacker, S
Kallen, A
Lofdahl, CG
Citation: L. Thorsson et al., Pharmacokinetics and systemic activity of fluticasone via Diskus (R) and pMDI, and of budesonide via Turbuhaler (R), BR J CL PH, 52(5), 2001, pp. 529-538
Authors:
Lofdahl, CG
Potma, DS
Eivindson, A
Schreurs, AJM
Rasidakis, A
Ekstrom, T
Tattersfield, AE
Citation: Cg. Lofdahl et al., On-demand relief treatment for asthma - Reply, LANCET, 357(9271), 2001, pp. 1882-1883
Authors:
Tattersfield, AE
Lofdahl, CG
Postma, DS
Eivindson, A
Schreurs, AGM
Rasidakis, A
Ekstrom, T
Citation: Ae. Tattersfield et al., Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial, LANCET, 357(9252), 2001, pp. 257-261
Authors:
Nihlen, U
Montnemery, P
Lindholm, LH
Lofdahl, CG
Citation: U. Nihlen et al., Increased serum levels of carbohydrate-deficient transferrin in patients with chronic obstructive pulmonary disease, SC J CL INV, 61(5), 2001, pp. 341-347
Authors:
Jacobson, L
Hertzman, P
Lofdahl, CG
Skoogh, BE
Lindgren, B
Citation: L. Jacobson et al., The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991, RESP MED, 94(3), 2000, pp. 247-255
Authors:
Ekberg-Jansson, A
Andersson, B
Arva, E
Nilsson, O
Lofdahl, CG
Citation: A. Ekberg-jansson et al., The expression of lymphocyte surface antigens in bronchial biopsies, bronchoalveolar lavage cells and blood cells in healthy smoking and never-smoking men, 60 years old, RESP MED, 94(3), 2000, pp. 264-272
Authors:
Tylen, U
Boijsen, M
Ekberg-Jansson, A
Bake, B
Lofdahl, CG
Citation: U. Tylen et al., Emphysematous lesions and lung function in healthy smokers 60 years of age, RESP MED, 94(1), 2000, pp. 38-43
Authors:
Montnemery, P
Lanke, J
Lindholm, LH
Lundback, B
Nyberg, P
Adelroth, E
Lofdahl, CG
Citation: P. Montnemery et al., Familial related risk-factors in the development of chronic bronchitis/emphysema as compared to asthma assessed in a postal survey, EUR J EPID, 16(11), 2000, pp. 1003-1007
Authors:
Tattersfield, AE
Postma, DS
Barnes, PJ
Svensson, K
Bauer, CA
O'Byrne, PM
Lofdahl, CG
Pauwels, RA
Ullman, A
Citation: Ae. Tattersfield et al., Exacerbations of asthma - A descriptive study of 425 severe exacerbations, AM J R CRIT, 160(2), 1999, pp. 594-599
Authors:
Lofdahl, CG
Reiss, TF
Leff, JA
Israel, E
Noonan, MJ
Finn, AF
Seidenberg, BC
Capizzi, T
Kundu, S
Godard, P
Citation: Cg. Lofdahl et al., Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients, BR MED J, 319(7202), 1999, pp. 87-90
Authors:
Ekberg-Jansson, A
Arva, E
Nilsson, O
Lofdahl, CG
Andersson, B
Citation: A. Ekberg-jansson et al., A comparison of the expression of lymphocyte activation markers in blood, bronchial biopsies and bronchoalveolar lavage: evidence for an enrichment of activated T lymphocytes in the bronchoalveolar space, RESP MED, 93(8), 1999, pp. 563-570
Authors:
Chung, KF
Godard, P
Adelroth, E
Ayres, J
Barnes, N
Barnes, P
Bel, E
Burney, P
Chanez, P
Connett, G
Corrigan, C
de Blic, J
Fabbri, L
Holgate, ST
Ind, P
Joos, G
Kerstjens, H
Leuenberger, P
Lofdahl, CG
McKenzie, S
Magnussen, H
Postma, D
Saetta, M
Salmeron, S
Silverman, M
Sterk, P
Citation: Kf. Chung et al., Difficult/therapy-resistant asthma - The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies, EUR RESP J, 13(5), 1999, pp. 1198-1208
Authors:
Nihlen, U
Montnemery, P
Lindholm, LH
Lofdahl, CG
Citation: U. Nihlen et al., Detection of chronic obstructive pulmonary disease (COPD) in primary health care: role of spirometry and respiratory symptoms, SC J PRIM H, 17(4), 1999, pp. 232-237
Authors:
Linden, A
Bergendal, A
Lotvall, J
Skoogh, BE
Lofdahl, CG
Citation: A. Linden et al., Effect of nedocromil sodium on non-adrenergic, non-cholinergic neural responses in guinea pig bronchi in vitro, REGUL PEPT, 81(1-3), 1999, pp. 49-53
Authors:
Pauwels, RA
Lofdahl, CG
Laitinen, LA
Schouten, JP
Postma, DS
Pride, NB
Ohlsson, SV
Citation: Ra. Pauwels et al., Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking, N ENG J MED, 340(25), 1999, pp. 1948-1953
Authors:
Larsson, S
Lofdahl, CG
Linden, M
Citation: S. Larsson et al., IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNF-alpha production by human mononuclear blood cells, BR J PHARM, 127(4), 1999, pp. 980-986
Authors:
Montnemery, P
Adelroth, E
Heuman, K
Johannisson, A
Johansson, SA
Lindholm, LH
Lundback, B
Lofdahl, CG
Citation: P. Montnemery et al., Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden, RESP MED, 92(12), 1998, pp. 1337-1345
Authors:
Nana, A
Youngchaiyud, P
Charoenratanakul, S
Boe, J
Lofdahl, CG
Selroos, O
Stahl, E
Citation: A. Nana et al., High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack, J ASTHMA, 35(8), 1998, pp. 647-655
Risultati:
1-25
|